X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5639) 5639
Publication (475) 475
Book Review (116) 116
Newsletter (32) 32
Book Chapter (28) 28
Book / eBook (12) 12
Conference Proceeding (9) 9
Magazine Article (7) 7
Data Set (2) 2
Dissertation (2) 2
Paper (2) 2
Transcript (2) 2
Web Resource (2) 2
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (4214) 4214
index medicus (2981) 2981
male (2416) 2416
female (1971) 1971
cardiac & cardiovascular systems (1689) 1689
heart failure (1617) 1617
natriuretic peptides (1522) 1522
middle aged (1488) 1488
animals (1467) 1467
aged (1336) 1336
brain natriuretic peptide (1134) 1134
heart failure - drug therapy (1067) 1067
natriuretic peptide, brain - blood (1041) 1041
mortality (839) 839
pharmacology & pharmacy (828) 828
natriuretic peptide (796) 796
treatment outcome (765) 765
prognosis (735) 735
adult (731) 731
biomarkers - blood (715) 715
heart failure - physiopathology (701) 701
hypertension (657) 657
rats (604) 604
risk factors (602) 602
care and treatment (601) 601
heart (585) 585
atrial-natriuretic-peptide (575) 575
cardiology (535) 535
heart-failure (502) 502
cardiovascular (479) 479
analysis (471) 471
diagnosis (467) 467
peptides (459) 459
peptide fragments - blood (455) 455
heart failure - diagnosis (432) 432
echocardiography (431) 431
biomarkers (428) 428
cardiac patients (428) 428
research (426) 426
heart failure - blood (424) 424
antihypertensive agents - therapeutic use (421) 421
medicine & public health (411) 411
prospective studies (408) 408
abridged index medicus (399) 399
health aspects (385) 385
cardiotonic agents - therapeutic use (378) 378
aged, 80 and over (375) 375
time factors (373) 373
atrial natriuretic factor - blood (366) 366
natriuretic peptide, brain - therapeutic use (360) 360
blood pressure - drug effects (357) 357
drug therapy (357) 357
blood pressure (350) 350
peripheral vascular disease (350) 350
medicine, general & internal (327) 327
myocardial-infarction (324) 324
heart diseases (323) 323
left-ventricular dysfunction (323) 323
cardiovascular disease (322) 322
natriuretic agents - therapeutic use (321) 321
acute disease (320) 320
hypertension - drug therapy (317) 317
angiotensin-converting enzyme inhibitors - therapeutic use (310) 310
internal medicine (305) 305
physiological aspects (304) 304
congestive-heart-failure (302) 302
rodents (292) 292
vasodilator agents - therapeutic use (291) 291
therapy (289) 289
atrial natriuretic peptide (288) 288
disease (287) 287
heart attacks (284) 284
acute myocardial-infarction (280) 280
follow-up studies (279) 279
double-blind (272) 272
double-blind method (272) 272
medicine, research & experimental (270) 270
heart failure - therapy (269) 269
dysfunction (268) 268
risk (262) 262
blood-pressure (259) 259
physiology (258) 258
diuretics - therapeutic use (252) 252
mice (251) 251
heart failure - mortality (246) 246
predictive value of tests (242) 242
article (240) 240
risk assessment (240) 240
angiotensin (239) 239
cardiovascular diseases (239) 239
hemodynamics (236) 236
pulmonary hypertension (234) 234
survival (231) 231
hemodynamics - drug effects (230) 230
dose-response relationship, drug (227) 227
patients (226) 226
studies (226) 226
c-reactive protein (225) 225
respiratory system (225) 225
hypertrophy (223) 223
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5596) 5596
Japanese (47) 47
French (25) 25
German (21) 21
Spanish (15) 15
Chinese (14) 14
Russian (12) 12
Italian (10) 10
Polish (6) 6
Portuguese (6) 6
Czech (2) 2
Croatian (1) 1
Dutch (1) 1
Norwegian (1) 1
Romanian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of the American College of Cardiology, ISSN 0735-1097, 04/2014, Volume 63, Issue 12, pp. 1123 - 1133
Heart failure is a global pandemic affecting an estimated 26 million people worldwide and resulting in more than 1 million hospitalizations annually in both... 
acute | heart failure | registry | hospitalization | inpatient | VENTRICULAR EJECTION FRACTION | CARDIAC & CARDIOVASCULAR SYSTEMS | QUALITY-OF-CARE | OPTIMIZE-HF REGISTRY | ORGANIZED PROGRAM | EUROBSERVATIONAL RESEARCH-PROGRAM | STROKE STATISTICS-2012 UPDATE | INITIATE LIFESAVING TREATMENT | ONE-YEAR MORTALITY | PHYSICIAN FOLLOW-UP | PRESERVED SYSTOLIC FUNCTION | Age Distribution | Vasodilator Agents - therapeutic use | Anemia - epidemiology | United States | Humans | Catheterization, Swan-Ganz - utilization | Male | Dyspnea - etiology | Cardiotonic Agents - therapeutic use | Heart Failure - therapy | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Electrocardiography | Female | Registries | Coronary Angiography - utilization | Heart Failure - diagnosis | Heart Failure - epidemiology | Heart Failure - etiology | Drug Utilization - statistics & numerical data | Length of Stay - statistics & numerical data | Adrenergic beta-Antagonists - therapeutic use | Hyponatremia - epidemiology | Cardiac Resynchronization Therapy - utilization | Echocardiography | Glomerular Filtration Rate | Hospital Mortality | Comorbidity | Europe | Defibrillators, Implantable - utilization | Hospitalization | Evidence-Based Medicine | Mineralocorticoid Receptor Antagonists - therapeutic use | Stroke Volume | Quality Improvement | Asia | Natriuretic Peptides - analysis | Sex Distribution | Diuretics - therapeutic use | Aged | Angiotensin Receptor Antagonists - therapeutic use | Heart failure | Medical colleges | Medical research | Mortality | Therapeutics | Economic aspects | Medicine, Experimental | Natriuretic peptides | Homeopathy | Materia medica and therapeutics
Journal Article
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 12/2014, Volume 64, Issue 21, pp. e1 - e76
Journal Article
European heart journal, ISSN 0195-668X, 2012, Volume 33, Issue 14, pp. 1787 - 1847
Journal Article
Circulation, ISSN 0009-7322, 2015, Volume 131, Issue 17, pp. 1486 - 1494
Background Our aim was to describe the incidence and predictors of stroke in patients who have heart failure without atrial fibrillation (AF). Methods and... 
Heart failure | Stroke | Sinus rhythm | Atrial fibrillation | Risk factors | Ventricular ejection fraction | heart failure | risk factors | CARDIAC & CARDIOVASCULAR SYSTEMS | VENTRICULAR SYSTOLIC FUNCTION | RANDOMIZED-TRIAL | NATRIURETIC PEPTIDE | stroke | ASPIRIN | atrial fibrillation | CONVERTING-ENZYME INHIBITORS | THERAPY | WARFARIN | EJECTION FRACTION | ventricular ejection fraction | sinus rhythm | PERIPHERAL VASCULAR DISEASE | CANDESARTAN | THROMBOEMBOLISM | Follow-Up Studies | Humans | Middle Aged | Male | Diabetes Mellitus, Type 1 - complications | Peptide Fragments - blood | Aged, 80 and over | Adult | Female | Stroke - epidemiology | Natriuretic Peptide, Brain - blood | Benzimidazoles - therapeutic use | Heart Failure - complications | Stroke - prevention & control | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Rosuvastatin Calcium | Biomarkers - blood | Heart Failure - drug therapy | Randomized Controlled Trials as Topic | Stroke Volume | Cardiovascular Agents - therapeutic use | Stroke - etiology | Sulfonamides - therapeutic use | Pyrimidines - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Atrial Fibrillation - etiology | Fatty Acids, Omega-3 - therapeutic use | Tetrazoles - therapeutic use | Aged | Fluorobenzenes - therapeutic use | Fatty Acids | Peptide Fragments/ blood | Omega-3/ therapeutic use | Tetrazoles/therapeutic use | Sulfonamides/ therapeutic use | Kardiologi | 80 and over | Biological Markers/blood | Natriuretic Peptide | Pyrimidines/ therapeutic use | Cardiovascular Agents/therapeutic use | Stroke/epidemiology/ etiology/prevention & control | Benzimidazoles/therapeutic use | Diabetes Mellitus | Type 1/complications | Brain/ blood | Cardiac and Cardiovascular Systems | Atrial Fibrillation/etiology | Fluorobenzenes/ therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors/ therapeutic use | Heart Failure/complications/ drug therapy
Journal Article
Journal Article